시장보고서

상품코드

1605911

원료의약품 시장 규모, 점유율, 동향, 산업 분석 리포트 : 제품 유형별, 형태별, 제조업체 유형별, 용도별, 지역별 - 시장 예측(2025-2034년)

Active Pharmaceutical Ingredient Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form, Manufacturer Type, Application, and Region - Market Forecast, 2025-2034

발행일: 2024년 11월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 120 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 원료의약품(API) 시장 규모는 2034년까지 4,369억 달러에 달할 전망입니다. 본 리포트에서는 현재 시장 역학의 상세 인사이트를 제공하고, 향후 시장 성장에 관한 분석을 제공하고 있습니다.

의약품 유효성분(API) 시장의 성장은 세계 제네릭 및 일반의약품에 대한 수요 증가에 힘입어 성장세를 보이고 있습니다. 예를 들어 미국의 일반의약품 소매 매출은 2000년 147억 달러에서 2023년 434억 달러로 증가할 것으로 예상됩니다. 이는 2000-2023년 330억 달러가 크게 증가한 것을 의미합니다. 또한 2018-2023년 OTC 의약품 매출은 3.6% 증가했습니다.

공공 및 민간 자본의 투자 및 자금 조달이 증가함에 따라 의약품 활성 성분 시장의 성장이 촉진될 것으로 예상됩니다. 의약품의 제형화, 생산 및 신약 개발 기간 단축의 발전은 더 나은 투자 매출을 원하는 투자자들을 끌어들이고 있습니다. 예를 들어 2024년 8월 주사제 선도기업인 비빈트 파마는 하이데라바드의 유전체 밸리에 첨단 주사제 제조 시설을 건설할 계획을 발표했습니다. 이 회사는 이 새로운 시설에 4,800만 달러를 투자하여 1,000개의 일자리를 창출하고 텔랑가나주의 세계 생명과학 거점으로서의 입지를 강화할 것으로 예상됩니다. 이번 발표는 미국에서 열린 스리 A. 레반스 레디(Shri A. Revanth Reddy) 텔랑가나 주 총리와 스리 D. 스리다르 밥(Shri D. Sridhar Babu) 산업 및 상업부 장관과의 고위급 회담에서 이루어졌습니다. 비빈트 파마는 이미 유전체 밸리에 850만 달러 규모의 R&D 센터를 보유하고 있으며, 인도에서 거점을 확장하고 있습니다. 회사는 국제 시장 진출을 지원하기 위해 세계적 수준의 인프라와 혁신 생태계로 유명한 유전체 밸리에 5.5에이커의 부지를 확보했습니다.

제약회사는 의약품 유효성분의 주요 수요자이자 생산자이기도 합니다. 투자 증가와 정부의 우대 정책으로 인해 혁신적인 아이디어를 가진 신규 진출기업이 증가하여 기존 대형 제약사에 도전하고 있습니다.

의약품 활성 성분(API) 시장 보고서 하이라이트

형태별 분석에 따르면 수성 부문은 높은 CAGR을 보이며 시장이 크게 성장할 것으로 예상됩니다. 이러한 성장은 다양한 형태의 의약품에 수성 원료의약품이 광범위하게 사용되고 있기 때문입니다.

2024년, 북미가 API 시장을 장악했습니다.

중국의 활성 제약 성분(API) 시장은 중국내 바이오 기술 혁신에 대한 규제 지원과 자금 지원으로 인해 큰 폭의 성장이 예상됩니다.

주요 시장 기업은 Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.입니다.

시장 스냅숏
원료의약품(API) 시장 역학
- 촉진요인과 기회
  - 의약품 분야에 대한 투자 증가가 시장 규모를 촉진하고 있다.
  - 파이프라인 의약품의 증가가 시장의 성장을 촉진
- 억제요인과 과제
  - 숙련 노동력의 부족
PESTEL 분석
원료의약품(API) 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 원료의약품(API) 시장 : 제품 유형별

주요 조사 결과
서론
모노클로널 항체
면역글로불린
사이토카인
인슐린
펩티드 호르몬
혈액 인자
펩티드 항생제
백신
저분자 항생제
고효능 원료의약품(HPAPI)
기타

제6장 세계의 원료의약품(API) 시장 : 형태별

주요 조사 결과
서론
수성 액체
비수성 액체
건조 분말

제7장 세계의 원료의약품(API) 시장 : 제조업체 유형별

주요 조사 결과
서론
자사용
외판용

제8장 세계의 원료의약품(API) 시장 : 용도별

주요 조사 결과
서론
심장병학
종양학
중추신경계와 신경학
정형외과
내분비학
호흡기과
소화기 내과
신장학
안과
기타

제9장 세계의 원료의약품(API) 시장 : 지역별

주요 조사 결과
서론
- 원료의약품(API) 시장 평가 : 지역, 2020-2034년
북미
- 북미 : 제품 유형별, 2020-2034년
- 북미 : 형태별, 2020-2034년
- 북미 : 제조업체 유형별, 2020-2034년
- 북미 : 애플리케이션별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 제품 유형별, 2020-2034년
- 유럽 : 형태별, 2020-2034년
- 유럽 : 제조업체 유형별, 2020-2034년
- 유럽 : 애플리케이션별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제품 유형별, 2020-2034년
- 아시아태평양 : 형태별, 2020-2034년
- 아시아태평양 : 제조업체 유형별, 2020-2034년
- 아시아태평양 : 애플리케이션별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제품 유형별, 2020-2034년
- 중동 및 아프리카 : 형태별, 2020-2034년
- 중동 및 아프리카 : 제조업체 유형별, 2020-2034년
- 중동 및 아프리카 : 애플리케이션별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제품 유형별, 2020-2034년
- 라틴아메리카 : 형태별, 2020-2034년
- 라틴아메리카 : 제조업체 유형별, 2020-2034년
- 라틴아메리카 : 애플리케이션별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 개요

Pfizer
Teva Pharmaceuticals Ltd
GSK PLC
Sanofi
Eli Lilly and Company
Merck KGaA
AbbVie Inc.
F-Hoffman La Roche Ltd
AstraZeneca
Dr. Reddy's Laboratory
BASF Corporation
Sun Pharmaceuticals Industries Ltd.
Curia Global Inc.
Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

KSA 25.01.06

The active pharmaceutical ingredient market size is expected to reach USD 436.90 billion by 2034, according to a new study by Polaris Market Research. The report "Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form (Aqueous, Non-Aqueous Liquid, and Dry Powder), Manufacturer Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The active pharmaceutical ingredient (API) market growth is driven by increasing demand for generic drugs and over-the-counter drugs worldwide. For instance, the retail sales of over-the-counter drugs in the US have risen to 43.4 billion USD in 2023 from 14.7 billion dollar USD in 2000. This represents a significant increase of 33 billion dollar USD from 2000 to 2023. Additionally, the sales revenue of OTC drugs from 2018 to 2023 has grown by 3.6%

Increasing investments and funding from public and private capitalists are anticipated to fuel active pharmaceutical market growth. Advancements in drug formulations, production, and short drug discovery timelines have been attracting investors seeking better returns on their investments. For instance, in August 2024, Vivint Pharma, a leading injectables pharmaceutical company, announced plans to build an advanced injectables manufacturing facility in Genome Valley, Hyderabad. The company will invest $48 million in the new facility, which is expected to create 1,000 jobs and strengthen Telangana's position as a global life sciences hub. The announcement was made during a high-level meeting with Telangana's Chief Minister, Shri A. Revanth Reddy, and Minister for Industries and Commerce, Sri D. Sridhar Babu, in the US. Vivint Pharma, which already has a $8.5 million R&D center in Genome Valley, is expanding its footprint in India. The company has acquired 5.5 acres in Genome Valley, known for its world-class infrastructure and innovation ecosystem, to support its entry into international markets.

Pharmaceutical companies are major consumers and manufacturers of active pharmaceutical ingredients. Increasing investment and government incentives have led to a rise in the number of new players with innovative ideas, challenging the existing pharmaceutical giants.

Active Pharmaceutical Ingredient (API) Market Report Highlights

By form analysis, the aqueous segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to the wide range of applications of the aqueous active pharmaceutical ingredient in different forms of drugs.

In 2024, North America dominated the API market due to the established presence of several companies within the region.

The active pharmaceutical ingredient (API) market in China is projected for substantial growth due to the regulatory support and funding for biotech innovations within the country.

The key market players are Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the active pharmaceutical ingredient market report based on product type, form, manufacturer type, application, and region:

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

mAb
Immunoglobulin
Cytokines
Insulin
Peptide Hormones
Blood Factors
Peptide Antibiotics
Vaccines
Small Molecule Antibiotics
Highly Potent Active Pharmaceutical Ingredient (HPAPI)
Others

By Form Outlook (Revenue - USD Billion, 2020-2034)

Aqueous
Non-Aqueous Liquid
Dry Powder

By Manufacturer Type Outlook (Revenue - USD Billion, 2020-2034)

Captive
Merchant

By Application Outlook (Revenue - USD Billion, 2020-2034)

Cardiology
Oncology
CNS & Neurology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Active Pharmaceutical Ingredient (API) Market Insights

4.1. Active Pharmaceutical Ingredient (API) Market - Market Snapshot
4.2. Active Pharmaceutical Ingredient (API) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Investment in Pharmaceutical Sector is Driving the Market Size
  - 4.2.1.2. Increasing Number of Pipeline Drugs Are Driving the Market Growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Skilled Workforce
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Active Pharmaceutical Ingredient (API) Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Active Pharmaceutical Ingredient (API) Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
5.3. mAb
- 5.3.1. Global Active Pharmaceutical Ingredient (API) Market, by mAb, by Region, 2020-2034 (USD Billion)
5.4. Immunoglobulin
- 5.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Immunoglobulin, by Region, 2020-2034 (USD Billion)
5.5. Cytokines
- 5.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Cytokines, by Region, 2020-2034 (USD Billion)
5.6. Insulin
- 5.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Insulin, by Region, 2020-2034 (USD Billion)
5.7. Peptide Hormones
- 5.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Hormones, by Region, 2020-2034 (USD Billion)
5.8. Blood Factors
- 5.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Blood Factors, by Region, 2020-2034 (USD Billion)
5.9. Peptide Antibiotics
- 5.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Antibiotics, by Region, 2020-2034 (USD Billion)
5.10. Vaccines
- 5.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Vaccines, by Region, 2020-2034 (USD Billion)
5.11. Small Molecule Antibiotics
- 5.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Small Molecule Antibiotics, by Region, 2020-2034 (USD Billion)
5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
- 5.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2020-2034 (USD Billion)
5.13. Others
- 5.13.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Active Pharmaceutical Ingredient (API) Market, by Form

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
6.3. Aqueous
- 6.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Aqueous, by Region, 2020-2034 (USD Billion)
6.4. Non-Aqueous Liquid
- 6.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Non-Aqueous Liquid, by Region, 2020-2034 (USD Billion)
6.5. Dry Powder
- 6.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Dry Powder, by Region, 2020-2034 (USD Billion)

7. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
7.3. Captive
- 7.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Captive, by Region, 2020-2034 (USD Billion)
7.4. Merchant
- 7.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Merchant, by Region, 2020-2034 (USD Billion)

8. Global Active Pharmaceutical Ingredient (API) Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
8.3. Cardiology
- 8.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Cardiology, by Region, 2020-2034 (USD Billion)
8.4. Oncology
- 8.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Oncology, by Region, 2020-2034 (USD Billion)
8.5. CNS & Neurology
- 8.5.1. Global Active Pharmaceutical Ingredient (API) Market, by CNS & Neurology, by Region, 2020-2034 (USD Billion)
8.6. Orthopedic
- 8.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Orthopedic, by Region, 2020-2034 (USD Billion)
8.7. Endocrinology
- 8.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
8.8. Pulmonology
- 8.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Pulmonology, by Region, 2020-2034 (USD Billion)
8.9. Gastroenterology
- 8.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
8.10. Nephrology
- 8.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
8.11. Ophthalmology
- 8.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2020-2034 (USD Billion)
8.12. Others
- 8.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Active Pharmaceutical Ingredient (API) Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Active Pharmaceutical Ingredient (API) Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Active Pharmaceutical Ingredient (API) Market - North America
- 9.3.1. North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
- 9.3.3. North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
- 9.3.4. North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.3.5. Active Pharmaceutical Ingredient (API) Market - U.S.
  - 9.3.5.1. U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.3.5.2. U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.3.5.3. U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.3.5.4. U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.3.6. Active Pharmaceutical Ingredient (API) Market - Canada
  - 9.3.6.1. Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
9.4. Active Pharmaceutical Ingredient (API) Market - Europe
- 9.4.1. Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
- 9.4.3. Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
- 9.4.4. Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.5. Active Pharmaceutical Ingredient (API) Market - UK
  - 9.4.5.1. UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.6. Active Pharmaceutical Ingredient (API) Market - France
  - 9.4.6.1. France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.7. Active Pharmaceutical Ingredient (API) Market - Germany
  - 9.4.7.1. Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.8. Active Pharmaceutical Ingredient (API) Market - Italy
  - 9.4.8.1. Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.9. Active Pharmaceutical Ingredient (API) Market - Spain
  - 9.4.9.1. Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.10. Active Pharmaceutical Ingredient (API) Market - Netherlands
  - 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.11. Active Pharmaceutical Ingredient (API) Market - Russia
  - 9.4.11.1. Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.4.12. Active Pharmaceutical Ingredient (API) Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
9.5. Active Pharmaceutical Ingredient (API) Market - Asia Pacific
- 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.5. Active Pharmaceutical Ingredient (API) Market - China
  - 9.5.5.1. China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.6. Active Pharmaceutical Ingredient (API) Market - India
  - 9.5.6.1. India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.7. Active Pharmaceutical Ingredient (API) Market - Malaysia
  - 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.8. Active Pharmaceutical Ingredient (API) Market - Japan
  - 9.5.8.1. Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.9. Active Pharmaceutical Ingredient (API) Market - Indonesia
  - 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.10. Active Pharmaceutical Ingredient (API) Market - South Korea
  - 9.5.10.1. South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.11. Active Pharmaceutical Ingredient (API) Market - Australia
  - 9.5.11.1. Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.5.12. Active Pharmaceutical Ingredient (API) Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
9.6. Active Pharmaceutical Ingredient (API) Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.6.5. Active Pharmaceutical Ingredient (API) Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.6.6. Active Pharmaceutical Ingredient (API) Market - UAE
  - 9.6.6.1. UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.6.7. Active Pharmaceutical Ingredient (API) Market - Israel
  - 9.6.7.1. Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.6.8. Active Pharmaceutical Ingredient (API) Market - South Africa
  - 9.6.8.1. South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.6.9. Active Pharmaceutical Ingredient (API) Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
9.7. Active Pharmaceutical Ingredient (API) Market - Latin America
- 9.7.1. Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.7.5. Active Pharmaceutical Ingredient (API) Market - Mexico
  - 9.7.5.1. Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.7.6. Active Pharmaceutical Ingredient (API) Market - Brazil
  - 9.7.6.1. Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.7.7. Active Pharmaceutical Ingredient (API) Market - Argentina
  - 9.7.7.1. Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)
- 9.7.8. Active Pharmaceutical Ingredient (API) Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Pfizer
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Teva Pharmaceuticals Ltd
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. GSK PLC
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Sanofi
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Eli Lilly and Company
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck KGaA
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. AbbVie Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. F-Hoffman La Roche Ltd
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. AstraZeneca
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Dr. Reddy's Laboratory
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. BASF Corporation
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Sun Pharmaceuticals Industries Ltd.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Curia Global Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development